DK0968723T3 - Sårheling eller helbredelse af fibrotiske lidelser ved anvendelse af mindst ét middel mod en vækstfaktor - Google Patents

Sårheling eller helbredelse af fibrotiske lidelser ved anvendelse af mindst ét middel mod en vækstfaktor

Info

Publication number
DK0968723T3
DK0968723T3 DK99201184T DK99201184T DK0968723T3 DK 0968723 T3 DK0968723 T3 DK 0968723T3 DK 99201184 T DK99201184 T DK 99201184T DK 99201184 T DK99201184 T DK 99201184T DK 0968723 T3 DK0968723 T3 DK 0968723T3
Authority
DK
Denmark
Prior art keywords
healing
growth factor
fibrotic disorders
agent against
wound healing
Prior art date
Application number
DK99201184T
Other languages
English (en)
Inventor
Mark William James Ferguson
Shah Mamta
Original Assignee
Renovo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9406154A external-priority patent/GB2288118A/en
Priority claimed from GBGB9424898.6A external-priority patent/GB9424898D0/en
Application filed by Renovo Ltd filed Critical Renovo Ltd
Application granted granted Critical
Publication of DK0968723T3 publication Critical patent/DK0968723T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK99201184T 1994-03-29 1995-03-29 Sårheling eller helbredelse af fibrotiske lidelser ved anvendelse af mindst ét middel mod en vækstfaktor DK0968723T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9406154A GB2288118A (en) 1994-03-29 1994-03-29 Wound healing composition
GBGB9424898.6A GB9424898D0 (en) 1994-12-09 1994-12-09 Wound healing
PCT/GB1995/000704 WO1995026203A1 (en) 1994-03-29 1995-03-29 Wound healing

Publications (1)

Publication Number Publication Date
DK0968723T3 true DK0968723T3 (da) 2009-11-09

Family

ID=26304595

Family Applications (2)

Application Number Title Priority Date Filing Date
DK99201184T DK0968723T3 (da) 1994-03-29 1995-03-29 Sårheling eller helbredelse af fibrotiske lidelser ved anvendelse af mindst ét middel mod en vækstfaktor
DK95913237T DK0754058T3 (da) 1994-03-29 1995-03-29 Sårheling

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK95913237T DK0754058T3 (da) 1994-03-29 1995-03-29 Sårheling

Country Status (12)

Country Link
US (1) US5972335A (da)
EP (2) EP0754058B1 (da)
JP (1) JP4083794B2 (da)
AT (2) ATE186220T1 (da)
AU (1) AU710153B2 (da)
CA (1) CA2186269C (da)
DE (2) DE69513158T2 (da)
DK (2) DK0968723T3 (da)
ES (2) ES2329531T3 (da)
GR (1) GR3032266T3 (da)
NZ (1) NZ282856A (da)
WO (1) WO1995026203A1 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9106678D0 (en) * 1991-03-28 1991-05-15 Ferguson Mark W J Wound healing
GB2304047A (en) 1995-08-09 1997-03-12 Univ Manchester Pharmaceutical compositions containing cytokines
GB9601081D0 (en) * 1995-10-06 1996-03-20 Cambridge Antibody Tech Specific binding members for human transforming growth factor beta;materials and methods
GB2306481A (en) * 1995-10-21 1997-05-07 Univ Manchester Pharmaceutical comprising a stimulator of activin and/or inhibin
GB9702943D0 (en) * 1997-02-13 1997-04-02 Univ Manchester Wound healing
DE10022074A1 (de) * 2000-05-06 2001-11-08 Henkel Kgaa Elektrochemisch erzeugte Schichten zum Korrosionsschutz oder als Haftgrund
US6509318B1 (en) * 2000-09-29 2003-01-21 The Regents Of The University Of California TGF-B inhibitors and methods
US7569132B2 (en) * 2001-10-02 2009-08-04 Henkel Kgaa Process for anodically coating an aluminum substrate with ceramic oxides prior to polytetrafluoroethylene or silicone coating
US7452454B2 (en) * 2001-10-02 2008-11-18 Henkel Kgaa Anodized coating over aluminum and aluminum alloy coated substrates
GB0217136D0 (en) * 2002-07-24 2002-09-04 Renovo Ltd Wound healing & treatment of fibrosis
US20050074453A1 (en) * 2003-10-02 2005-04-07 Ferree Bret A. Methods of preventing adhesions following laminectomies and other surgical procedures
EP1740615B1 (en) 2004-03-31 2014-11-05 Genentech, Inc. Humanized anti-tgf-beta antibodies
EP2498798A4 (en) * 2009-11-10 2014-01-01 Univ Columbia COMPOSITIONS AND METHODS OF WOUND TREATMENT
WO2011109808A1 (en) * 2010-03-05 2011-09-09 Wake Forest University Health Sciences Controlled delivery system
US10385095B2 (en) 2011-08-17 2019-08-20 Keratin Biosciences, Inc Methods for extracting keratin proteins
AU2012296490B2 (en) 2011-08-17 2017-09-07 Keratin Biosciences, Inc. Low protein percentage gelling compositions
JP2016500704A (ja) * 2012-11-06 2016-01-14 スカラー ロック インコーポレイテッドＳｃｈｏｌａｒ Ｒｏｃｋ，Ｉｎｃ． 細胞シグナル伝達を変調するための組成物及び方法
US9827245B2 (en) 2013-03-15 2017-11-28 KeraNetics, LLC Keratin compositions comprising halofuginone
RS61778B1 (sr) 2013-05-06 2021-06-30 Scholar Rock Inc Kompozicije i postupci za modulaciju faktora rasta
AU2017268234A1 (en) 2016-05-17 2018-12-13 Genentech, Inc. Stromal gene signatures for diagnosis and use in immunotherapy
TW201923089A (zh) 2017-11-06 2019-06-16 美商建南德克公司 癌症之診斷及治療方法
WO2023080900A1 (en) 2021-11-05 2023-05-11 Genentech, Inc. Methods and compositions for classifying and treating kidney cancer
WO2024077095A1 (en) 2022-10-05 2024-04-11 Genentech, Inc. Methods and compositions for classifying and treating bladder cancer
EP4599088A1 (en) 2022-10-05 2025-08-13 Genentech, Inc. Methods and compositions for classifying and treating lung cancer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU624789B2 (en) * 1987-02-19 1992-06-25 Amgen, Inc. Purified platelet-derived growth factor and methods for purification thereof
US5094941A (en) * 1987-12-31 1992-03-10 Zymogenetics, Inc. Monoclonal antibodies to PDGF
FI921353A0 (fi) * 1989-09-29 1992-03-27 Jolla Cancer Res Found Inhibering av transformerande vaextfaktor b foer foerhindrande av ackumulation av extracellulaer matris.
GB9106678D0 (en) * 1991-03-28 1991-05-15 Ferguson Mark W J Wound healing
JP3854307B2 (ja) * 1991-12-04 2006-12-06 ザ バーナム インスティテュート 細胞外マトリックスの蓄積を防止するためのトランスフォーミング増殖因子βの阻害
GB9206861D0 (en) * 1992-03-28 1992-05-13 Univ Manchester Wound healing and treatment of fibrotic disorders
WO1993019783A1 (en) * 1992-04-01 1993-10-14 The Whittier Institute For Diabetes And Endocrinology Methods of inhibiting or enhancing scar formation in the cns
GB9217206D0 (en) 1992-08-13 1992-09-23 Pointer John C Photo labels
WO1994009812A1 (en) * 1992-10-26 1994-05-11 Kirin Brewery Company, Limited METHOD FOR PRODUCING LARGE LATENT TRANSFORMING GROWTH FACTOR-β COMPLEXES AND LARGE LATENCY ASSOCIATED PEPTIDE
JP4350370B2 (ja) * 2002-12-27 2009-10-21 株式会社半導体エネルギー研究所 電子回路及び電子機器

Also Published As

Publication number Publication date
ES2329531T3 (es) 2009-11-26
JP4083794B2 (ja) 2008-04-30
AU710153B2 (en) 1999-09-16
AU2077895A (en) 1995-10-17
GR3032266T3 (en) 2000-04-27
CA2186269C (en) 2008-06-03
DE69535976D1 (de) 2009-08-13
EP0968723B1 (en) 2009-07-01
CA2186269A1 (en) 1995-10-05
ATE186220T1 (de) 1999-11-15
EP0754058B1 (en) 1999-11-03
EP0968723A1 (en) 2000-01-05
DK0754058T3 (da) 2000-02-07
ATE435030T1 (de) 2009-07-15
EP0754058A1 (en) 1997-01-22
ES2140670T3 (es) 2000-03-01
NZ282856A (en) 1998-06-26
DE69513158D1 (de) 1999-12-09
WO1995026203A1 (en) 1995-10-05
JPH09510967A (ja) 1997-11-04
US5972335A (en) 1999-10-26
DE69513158T2 (de) 2000-05-04

Similar Documents

Publication Publication Date Title
DK0968723T3 (da) Sårheling eller helbredelse af fibrotiske lidelser ved anvendelse af mindst ét middel mod en vækstfaktor
ATE247483T1 (de) Matrixprotein enthaltende zusammensetzungen für entzündliche und infektiöse zustände
DE69530926D1 (de) Mittel zur förderung des haarwachstums
DE69524682D1 (de) Mittel zur Behandlung von Wunden
FI973828A0 (fi) Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi
FI972169A7 (fi) Lämpöä kestäviä polyolefiinikoostumuksia, joissa heksaaniin uuttuvien aineosien pitoisuus on pieni ja joilla on kontrolloitu moduuli
ATE275930T1 (de) Haarwuchszusammensetzungen und deren verwendungen
FI940932L (fi) Koostumuksia ja menetelmiä haavojen hoitamiseksi
EE9900345A (et) Sulfonüülkarbamiidi ja glitasooni sünergistilised kombinatsioonid diabeedi raviks
CY1108110T1 (el) Παραγοντες και μεθοδοι για προστασια, θεραπεια και επιδιορθωση συνδετικου ιστου
DE69019363D1 (de) Desinfizierende zusammensetzung und desinfektionsverfahren.
DE69932510D1 (de) Vaskularisierungsinhibitoren
ATE473749T1 (de) Verwendung von rhamnolipiden zur wundheilung, behandlung und vorbeugung einer zahnfleischerkrankung und periodontaler regeneration
ATE302581T1 (de) Oxydierungszusammensetzung zur anwendung in der behandlung von keratinischen fasern
DE69405919D1 (de) Zusammensetzungen zur Behandlung von Keratinfasern
GR3029436T3 (en) Preparations for the external application of antiseptic agents and/or agents promoting the healing of wounds.
DE69910202D1 (de) EGR-1 zur Herstellung eines Medikamentes zur Behandlung von Wunden
ATE235245T1 (de) Pharmaceutische komposition
DE69535366D1 (de) Zusammensetzung zur behandlung und vorbeugung von hiv-1 infektionen, welche mindestens zwei verschiedene hiv-1 reverse transcriptase inhibitoren enthalt
DE69808663D1 (de) Neomycin/disaccharid wässerige lösung zur behandlung von enteroclysis bei hepatischer enzephalopathie
DE59901831D1 (de) Wirkstoffkombinationen und Desinfektionsmittel, Konservierungsmittel und Antiseptika dieselben enthaltend
AU4166599A (en) Glucopyranose derivatives and preventives and/or remedies for hiv infection containing the same as the active ingredient
DE69838981D1 (de) Komponente und Zusammensetzungen zur Verabreichung von Wirkstoffen